Mon.Aug 05, 2024

article thumbnail

Novartis and Viatris sued by estate of Henrietta Lacks, whose cells were extracted for research in 1951

Fierce Pharma

The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from | The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from the discoveries they made using her genetic material.

Medical 363
article thumbnail

Bayer Looks to Expand Kerendia’s Label to Heart Failure After Phase 3 Win

MedCity News

Bayer reported a Phase 3 test of Kerendia in heart failure led to statistically significant reductions in cardiovascular death and hospitalizations. Detailed results will be presented during the European Society of Cardiology annual meeting in September. The post Bayer Looks to Expand Kerendia’s Label to Heart Failure After Phase 3 Win appeared first on MedCity News.

Biopharma 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market

Fierce Pharma

While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.

Marketing 363
article thumbnail

uniQure wields axe again as Huntington's therapy progresses

pharmaphorum

uniQure sheds two-thirds of its staff as it refocuses around a leaner pipeline headed by Huntington's therapy AMT-130

119
119
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Bristol Myers telegraphs layoffs in New Jersey, trimming 117 jobs in staggered wave of cuts

Fierce Pharma

Bristol Myers Squibb, while working its way through a major restructuring, has unveiled another round of layoffs in New Jersey. | Bristol Myers Squibb, while working its way through a major restructuring, has unveiled another round of layoffs in its home state of New Jersey.

312
312
article thumbnail

Most Physicians Are Excited About Clinical Documentation AI, Report Shows

MedCity News

While burnout levels may be improving slightly, physicians’ administrative burden still remains a major issue. Providers are hungry for more tools designed to simplify these tasks, namely documentation, a new report shows. The post Most Physicians Are Excited About Clinical Documentation AI, Report Shows appeared first on MedCity News.

More Trending

article thumbnail

Unlocking Value in Preventative Care: How MedTech Companies are Shifting Focus

MedCity News

The integration of AI holds the promise of catalyzing innovation and spearheading a healthcare reinvention. MedTech companies that can successfully integrate these technologies into their operations are poised not only to thrive but also to lead the transformation of healthcare delivery. The post Unlocking Value in Preventative Care: How MedTech Companies are Shifting Focus appeared first on MedCity News.

article thumbnail

As Krystal's Vyjuvek gains momentum, analysts spotlight 'transition point' in topical gene therapy launch

Fierce Pharma

Following a launch last summer, Krystal Biotech’s topical gene therapy Vyjuvek is continuing to make waves in the dystrophic epidermolysis bullosa (DEB) disease space. | The quarter marks a “transition point” in Vyjuvek’s launch, analysts at Evercore ISI wrote in a note to clients. While the analysts expect the drug's sales to keep growing, they cautioned of a potential slowdown in the third quarter and beyond as Krystal's initial commercial efforts shift to patient identification effo

Sales 246
article thumbnail

What Does the Future of the Food-As-Medicine Market Look Like?

MedCity News

During a webinar hosted by PitchBook, healthcare experts shared that the food-as-medicine space will likely see consolidation in the future, as well as advancements in technology and reimbursement. The post What Does the Future of the Food-As-Medicine Market Look Like? appeared first on MedCity News.

Food 111
article thumbnail

Discover Breakthrough Pharma Marketing Strategies at Digital Pharma East 2024

Fierce Pharma

The pharmaceutical industry is in a constant state of evolution, driven by technological advancements, shifting consumer behaviors, and a complex regulatory landscape. | Join us at Digital Pharma East 2024 on Sept. 9-12 in Philadelphia to learn, connect, and innovate with your life sciences marketing industry peers.

Pharma 212
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How Data and Technology Are Strengthening the Relationships Between Accountable Care Organizations and Skilled Nursing Facilities

MedCity News

With more SNFs being penalized and an increasing number of patients being referred to home health care, participating in an ACO may be a strategic solution to improving care coordination, organizational goals, and patient outcomes overall. The post How Data and Technology Are Strengthening the Relationships Between Accountable Care Organizations and Skilled Nursing Facilities appeared first on MedCity News.

Patients 110
article thumbnail

ETH Zurich researchers reveal how colorectal cancer cells colonise the liver

PharmaTimes

Bowel cancer, the third most common cancer type worldwide, is the second most common cause of cancer death

105
105
article thumbnail

EC grants orphan drug status for Amylyx’s Wolfram treatment

Pharmaceutical Technology

The European Commission (EC) has granted orphan drug designation (ODD) for Amylyx Pharmaceuticals’ AMX0035 to treat Wolfram syndrome.

article thumbnail

New study reveals certain bacteria are toxic for head and neck cancer

PharmaTimes

Head and neck cancer is currently recognised as the sixth most common cancer globally

96
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Bayer's finerenone clears key heart failure trial

pharmaphorum

At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered positive results in the space of a month.This morning, the German group revealed that mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) was able to reduce cardiovascular death and other heart failure events compared to placebo in the FINEARTS-HF trial.

85
article thumbnail

Human Pluripotent Stem Cell Line Variability Supports Successful Cortical Organoid Production

Pharmacy Times

Small adjustments in human pluripotent stem cell cultures and the molecule concentration patterns in the initial 5 days of differentiation are essential to “rescue” the lines.

62
article thumbnail

In a Duchenne market beset by problems, Capricor data marks a bright spot

PharmaVoice

The company’s cell therapy recently showed positive results from a mid-stage trial.

article thumbnail

Report: Satisfaction of Mail-Order Pharmacies Rise, Decreases for Community Pharmacies

Pharmacy Times

Customers report that their communication is strong with their pharmacists, but only 51% said their pharmacist was trustworthy.

61
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

MSD, Daiichi Sankyo lung cancer ADC starts phase 3

pharmaphorum

MSD and Daiichi Sankyo take anti-B7-H3 ADC ifinatamab deruxtecan (I-DXd) into phase 3 trial in small cell lung cancer

59
article thumbnail

Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and Pharmacists

Pharmacy Times

A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.

57
article thumbnail

23andMe board rebuffs CEO plan to take the firm private

pharmaphorum

A proposal by 23andMe founder and chief executive Anne Wojcicki to take the genetic testing company private has been rejected by a special committee of the board of directors.Wojcicki offered to buy all the shares in the company she does not already own last week for $0.40 apiece in cash, according to a Securities & Exchange Commission (SEC) filing, which indicated she and her associates own around 20% of the stock.

article thumbnail

Study: How mRNA-1345 RSV Vaccine Compares to Previously Approved RSV Vaccines

Pharmacy Times

The mRNA-1345 vaccine provides a one-off mechanism of protection because of its single-dose prefilled syringes

52
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Contracting Out Frees Sponsors Up

PharmaTech

Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.

article thumbnail

Research Suggests Alzheimer Disease and Periodontal Disease Are Linked by Inflammation

Pharmacy Times

Periodontitis and AD are both characterized by inflammatory and immunological response by the host.

52
article thumbnail

Evaluating Aseptic Processing and Manufacturing

PharmaTech

Webinar Date/Time: Thu, Aug 29, 2024 11:00 AM EDT

article thumbnail

MTD Group Acquires Ypsomed's Pen Needles, Blood Glucose Monitoring Systems

PharmExec

The acquisition of Ypsomed’s pen needles and blood glucose monitoring system is expected to increase MTD’s production capacity to over 2.5 billion units.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

First Gene Therapy for Adults with Metastatic Synovial Sarcoma Approved by FDA

PharmaTech

Synovial sarcoma is a rare form of cancer impacting about 1000 adults in the United States each year, most of them men in their 30s or younger.

FDA 52
article thumbnail

FDA Approves Expanded Indication for Octapharma’s Fibryga for Patients Experiencing Bleeding Due to Acquired Fibrinogen Deficiency

PharmExec

Expanded indication makes Fibryga the first and only on-demand, virus-inactivated, human plasma-derived fibrinogen concentrate approved for this indication.

article thumbnail

DKSH, Kyowa Kirin Sign Strategic Partnership

Pharmaceutical Commerce

Per the deal, DKSH inherits the specialty pharma company’s Asia-Pacific medication portfolio.

Pharma 52
article thumbnail

CVS Health Issues Statement Regarding Hurricane Debby’s Landfall

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A